51717 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 13
12:19 UTC
|
AOSL
Alpha and Omega Semiconductor
|
◎ Target | David Williams ★★★☆☆ #1335 | Buy | $50.00→ $45.00-10.0% |
|
Aug 13
12:19 UTC
|
ANRO
Alto Neuroscience
|
◎ Target | Thomas Shrader ★★☆☆☆ #2348 | Buy | $28.00→ $37.00+32.1% |
|
Aug 13
12:19 UTC
|
ANDG
Andersen Group
|
◎ Target | Tobey Sommer ★★★★☆ #796 | Buy | $42.00→ $55.00+31.0% |
|
Aug 13
12:19 UTC
|
ANDG
Andersen Group
|
◎ Target | Mark Marcon ★★★★☆ #611 | Outperform | $44.00→ $57.00+29.5% |
|
Aug 13
12:19 UTC
|
MNPR
Monopar Therapeutics
|
↓ Downgrade | Kristen Kluska ★☆☆☆☆ #3076 | Overweight→ Neutral | $109.00→ $119.00+9.2% |
|
Aug 13
12:19 UTC
|
BETR
Better Home & Finance
|
↓ Downgrade | Ramsey El-Assal not yet tracked | Overweight→ Neutral | $32.00→ $16.00-50.0% |
|
Aug 13
12:19 UTC
|
WYFI
WhiteFiber
|
↑ Upgrade | Brett Knoblauch ★☆☆☆☆ #3186 | Neutral→ Overweight | $27.00→ $36.00+33.3% |
|
Aug 13
12:19 UTC
|
HYLN
Hyliion
|
↑ Upgrade | Ted Jackson ★★★☆☆ #1860 | Market Perform→ Outperform | $10.00 |
|
Aug 13
12:19 UTC
|
CAVA
CAVA Group
|
↑ Upgrade | firm only | Sell→ Neutral | |
|
Aug 13
12:19 UTC
|
BIIB
Biogen
|
↑ Upgrade | firm only | Outperform | $300.00 |
|
Aug 13
12:19 UTC
|
ABBV
AbbVie
|
↑ Upgrade | firm only | Peer Perform→ Outperform | $300.00 |
|
Aug 13
11:19 UTC
|
SDLF
Standard Life
|
◎ Target | firm only | Overweight | GBX 975→ GBX 1,075+10.3% |
|
Aug 13
11:19 UTC
|
LGEN
Legal & General Group
|
◎ Target | firm only | Underweight | GBX 285→ GBX 270-5.3% |
|
Aug 13
11:19 UTC
|
UMGNF
Universal Music Group
|
↓ Downgrade | firm only | Hold→ Reduce | |
|
Aug 13
11:19 UTC
|
SYK
Stryker
|
↓ Downgrade | firm only | Buy→ Peer Perform | |
|
Aug 13
11:19 UTC
|
CCEP
Coca-Cola Europacific Partners
|
↓ Downgrade | Sanjeet Auija not yet tracked | Buy→ Neutral | |
|
Aug 13
11:19 UTC
|
WAY
Waystar
|
↑ Upgrade | firm only | Outperform | |
|
Aug 13
11:19 UTC
|
INO
Inovio Pharmaceuticals
|
↑ Upgrade | firm only | Positive | |
|
Aug 13
11:19 UTC
|
ESTA
Establishment Labs
|
↑ Upgrade | Joanne Wuensch ★★★★☆ #488 | Neutral→ Buy | |
|
Aug 13
11:19 UTC
|
DOCS
Doximity
|
↑ Upgrade | firm only | Outperform | |
|
Aug 13
11:19 UTC
|
BIIB
Biogen
|
↑ Upgrade | firm only | Outperform | |
|
Aug 13
11:19 UTC
|
ABBV
AbbVie
|
↑ Upgrade | firm only | Peer Perform→ Outperform | |
|
Aug 13
10:19 UTC
|
DHLGY
DHL Group
|
↓ Downgrade | firm only | Buy→ Neutral | |
|
Aug 13
10:19 UTC
|
SPRB
Spruce Biosciences
|
↑ Upgrade | firm only | Overweight | |
|
Aug 13
10:19 UTC
|
PHVS
Pharvaris
|
↑ Upgrade | firm only | Overweight | |
|
Aug 13
10:19 UTC
|
FIVE
Five Below
|
↑ Upgrade | Randal Konik ★★★★☆ #354 | Hold→ Buy | |
|
Aug 13
10:19 UTC
|
AMX
America Movil
|
↑ Upgrade | firm only | Neutral→ Outperform | |
|
Aug 13
09:19 UTC
|
BBY
Balfour Beatty
|
◎ Target | firm only | Buy | GBX 870→ GBX 1,070+23.0% |
|
Aug 13
09:19 UTC
|
AV
Aviva
|
◎ Target | firm only | Overweight | GBX 715→ GBX 800+11.9% |
|
Aug 13
08:19 UTC
|
AVVIY
Aviva
|
↓ Downgrade | firm only | Buy | |
|
Aug 13
08:19 UTC
|
ANNX
Annexon
|
↑ Upgrade | firm only | Underperform→ Market Perform | |
|
Aug 13
06:18 UTC
|
OI
O-I Glass
|
↓ Downgrade | Arun Viswanathan ★★★☆☆ #1698 | Outperform→ Sector Perform | $8.00 |
|
Aug 13
06:18 UTC
|
MNPR
Monopar Therapeutics
|
↓ Downgrade | firm only | Overweight→ Neutral | $119.00 |
|
Aug 13
06:18 UTC
|
SM
SM Energy
|
↑ Upgrade | Hanwen Chang ★★★☆☆ #1095 | Equal Weight→ Overweight | $47.00 |
|
Aug 13
06:18 UTC
|
SLGN
Silgan
|
↑ Upgrade | Arun Viswanathan ★★★☆☆ #1698 | Sec→ r Perform ➝ Outperform | $58.00 |
|
Aug 13
00:18 UTC
|
ZURA
Zura Bio
|
◎ Target | Yatin Suneja ★☆☆☆☆ #3119 | Buy | $15.00→ $20.00+33.3% |
|
Aug 13
00:18 UTC
|
ZURA
Zura Bio
|
◎ Target | Martin Fan ★★☆☆☆ #2568 | Outperform | $15.00→ $22.00+46.7% |
|
Aug 13
00:18 UTC
|
ZD
Ziff Davis
|
◎ Target | Stephen Ju ★★☆☆☆ #2525 | Neutral | $30.00→ $59.00+96.7% |
|
Aug 13
00:18 UTC
|
WMB
Williams Companies
|
◎ Target | Gabe Daoud not yet tracked | Buy | $84.00→ $88.00+4.8% |
|
Aug 13
00:18 UTC
|
WDAY
Workday
|
◎ Target | Michael Turrin ★★★☆☆ #1682 | Overweight | $185.00→ $215.00+16.2% |
|
Aug 13
00:18 UTC
|
WBI
WBI
|
◎ Target | Robert Kad ★★★☆☆ #1435 | Overweight | $38.00→ $43.00+13.2% |
|
Aug 13
00:18 UTC
|
VSTS
Vestis
|
◎ Target | Shlomo Rosenbaum ★★★★☆ #958 | Hold | $11.00→ $14.00+27.3% |
|
Aug 13
00:18 UTC
|
VSTS
Vestis
|
◎ Target | Andrew Wittmann ★★★☆☆ #2131 | Neutral | $15.00→ $16.00+6.7% |
|
Aug 13
00:18 UTC
|
VOR
Vor Biopharma
|
◎ Target | Martin Fan ★★☆☆☆ #2568 | Neutral | $18.00→ $27.00+50.0% |
|
Aug 13
00:18 UTC
|
VG
Venture Global
|
◎ Target | Praneeth Satish ★★★☆☆ #1674 | Equal Weight | $14.00→ $15.00+7.1% |
|
Aug 13
00:18 UTC
|
VERA
Vera Therapeutics
|
◎ Target | Arthur He not yet tracked | Buy | $125.00→ $90.00-28.0% |
|
Aug 13
00:18 UTC
|
USFD
US Foods
|
◎ Target | Brian Mullan ★☆☆☆☆ #3157 | Neutral | $88.00→ $108.00+22.7% |
|
Aug 13
00:18 UTC
|
URBN
Urban Outfitters
|
◎ Target | Corey Tarlowe ★★★☆☆ #1870 | Hold | $72.00→ $79.00+9.7% |
|
Aug 13
00:18 UTC
|
UPWK
Upwork
|
◎ Target | Maria Ripps ★★☆☆☆ #2422 | Hold | $10.00→ $9.00-10.0% |
|
Aug 13
00:18 UTC
|
ULVR
Unilever
|
◎ Target | firm only | Underperform | GBX 3,800→ GBX 3,900+2.6% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.